Lilly Reduces Zepbound® (Tirzepatide) Vial Prices
In a significant move to enhance accessibility, Eli Lilly and Company has announced a price reduction for Zepbound® (tirzepatide) single-dose vials. This decision further supports individuals dealing with obesity in the United States.
Lilly’s Price Reduction for Zepbound
Effective December 1, 2025, the updated pricing will be accessible via the LillyDirect platform. The lower costs follow the company’s recent announcement regarding the reduction in prices for Zepbound multi-dose pens, pending approval from the Food and Drug Administration (FDA).
New Pricing Details
Patients with a valid prescription can now purchase Zepbound with the following monthly prices:
- 2.5 mg: $299 (previously $349)
- 5 mg: $399 (previously $499)
- 7.5 mg: $449 (previously $499)
- 10 mg: $449 (previously $499)
- 12.5 mg: $449 (previously $499)
- 15 mg: $449 (previously $499)
For patients not enrolled in the Zepbound Self Pay Journey Program, prices are significantly higher. For instance, the 7.5 mg vial is priced at $599 without the program, while the 15 mg costs $1,049.
Commitment to Accessibility
Ilya Yuffa, Lilly’s Executive Vice President, emphasized the company’s dedication to minimizing cost and coverage barriers for obesity treatments. “Today’s action underscores Lilly’s commitment to improving access across the obesity care landscape,” he stated.
About Zepbound
Zepbound is an injectable prescription medication designed for adults suffering from obesity. It aids in weight loss and is also beneficial for individuals experiencing moderate-to-severe obstructive sleep apnea (OSA) associated with obesity. Doses available include 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg.
Doctors typically recommend administering the maintenance doses of 5 mg, 10 mg, or 15 mg once weekly for effective weight management.
Safety Information
While Zepbound offers therapeutic benefits, it is not without risks. Potential side effects include severe stomach issues, dehydration, and allergic reactions. Users are advised to consult healthcare providers regarding any adverse effects or concerns.
Learn More
To explore more about pricing, eligibility, and delivery options for Zepbound, visit Emegypt’s platform. The company continues its efforts to make healthcare more accessible to all individuals needing obesity management solutions.
